News for Healthier Living

Study: Olutasidenib is Highly Effective in Certain Patients with Myelodysplastic Syndrome

The targeted drug olutasidenib is highly effective in certain patients with myelodysplastic syndrome (MDS), a condition considered incurable without transplantation, according to a new clinical study led by researchers at Sylvester Comprehensive Cancer Center.

July 28, 2025


July 30 2025

July 29 2025

July 28 2025

July 26 2025

July 25 2025

July 24 2025

July 23 2025

July 22 2025

July 21 2025

July 20 2025

July 19 2025

July 18 2025

July 17 2025

July 16 2025